Risk group stratification to predict recurrence after transurethral resection in Japanese patients with stage Ta and T1 bladder tumours: validation study on the European Association of Urology guidelines-Reference-Cited by-同舟云学术

Risk group stratification to predict recurrence after transurethral resection in Japanese patients with stage Ta and T1 bladder tumours: validation study on the European Association of Urology guidelines

Published:2010-11-18 Issue:10 Volume:107 Page:1598-1604
ISSN:1464-4096
Container-title:BJU International
language:en
Short-container-title:

Author:

Sakano Shigeru,Matsuyama Hideyasu,Takai Kimio,Yoshihiro Satoru,Kamiryo Yoriaki,Shirataki Satoshi,Kaneda Yoshitaka,Hashimoto Osamu,Joko Keiji,Suga Akinobu,Yamamoto Mitsutaka,Hayashida Shigeaki,Baba Yoshikazu,Aoki Akihiko,

Publisher

Wiley

Subject

Urology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1464-410X.2010.09850.x/fullpdf

Reference23 articles.

1. Global cancer statistics, 2002;Parkin;CA Cancer J Clin,2005

2. Gene expression signatures predict outcome in non-muscle-invasive bladder carcinoma: a multicenter validation study;Dyrskjot;Clin Cancer Res,2007

3. Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials;Sylvester;Eur Urol,2006

4. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder;Babjuk;Eur Urol,2008

5. Re: Marko Babjuk, Willem Oosterlinck, Richard Sylvester, et al. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder. Eur Urol 2008;54:303-14;Orsola;Eur Urol,2009

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Validation of the risk stratification newly defined in the Japanese Urological Association guidelines 2019 for non‐muscle invasive bladder cancer: A multi‐institutional collaborative study;International Journal of Urology;2023-02-14

2. Significant impact of a history of prior or concomitant upper urinary tract cancer on the recurrence and progression of non-muscle invasive bladder cancer;Japanese Journal of Clinical Oncology;2022-04-23

3. Risk Stratification in Bladder Cancer;Management of Urology;2021

4. Serum soluble B7-H3 is a prognostic marker for patients with non-muscle-invasive bladder cancer;PLOS ONE;2020-12-11

5. Risk Stratification Tools and Prognostic Models in Non–muscle-invasive Bladder Cancer: A Critical Assessment from the European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel;European Urology Focus;2020-05